Strategy
MSTR
迪爾股份
DE
Steel Dynamics
STLD
4
Rumble
RUM
5
高盛
GS
美股市場個股詳情
NAUT Nautilus Biotechnology
- 1.710
- -0.010-0.58%
收盤價 02/14 16:00 (美東)
- 1.670
- -0.040-2.34%
盤後 20:01 (美東)
2.15億總市值-3.05市盈率TTM
1.760最高價1.690最低價3.99萬股成交量1.760今開1.720昨收6.87萬成交額0.09%換手率虧損市盈率(靜)1.26億總股本3.09052周最高0.96市淨率7887.09萬流通值1.56052周最低--股息TTM4612.33萬流通股25.886歷史最高--股息率TTM4.07%振幅1.500歷史最低1.724平均價1股每手
關於Nautilus Biotechnology公司
Nautilus Biotechnology Inc是一家處於發展階段的生命科學公司，創建了一個平臺技術，用於量化和解鎖人類蛋白質組的複雜性。它已經建立了一個單分子儀器的原型，蛋白質組分析系統(Proteomic Analysis System)。
公司介紹
公司代碼NAUT
公司名稱Nautilus Biotechnology
上市日期2020/08/07
發行價格10.00
成立日期2016
CEOMr. Sujal M. Patel
所屬市場納斯達克
員工數量167
年結日12-31
公司地址2701 Eastlake Avenue East
城市Seattle
省份華盛頓州
國家美國
郵編98102
電話1-206-333-2001
董事高管
- 姓名
- 職務
- 年薪
- Sujal M. Patel
- Chief Executive Officer, President, Secretary and Director
- 189.29萬
- Nick Nelson
- Chief Business Officer and Senior Vice President, Business Development
- --
- Gwen E. Weld
- Chief People Officer
- --
- Anna Mowry
- Chief Financial Officer, Principal Accounting Officer and Treasurer
- 78.15萬
- Dr. Subra Sankar
- Senior Vice President, Product Development
- --
- Mary E. Godwin
- Senior Vice President, Operations
- --
- Matthew L. Posard
- Chairman of the Board
- 24.70萬
- Dr. Parag Mallick, PhD
- Chief Scientist and Director
- 102.18萬
- Matthew S McIlwain
- Independent Director
- 20.30萬
- Dr. Vijay Pande, PhD
- Independent Director
- 18.80萬
- Dr. Karen Akinsanya, PhD
- Independent Director
- 18.80萬
- Melissa B. Epperly
- Independent Director
- 20.30萬
- Farzad Nazem
- Independent Director
- 19.00萬
- Michael Altman, C.F.A.
- Independent Director
- 19.00萬
- Matthew Murphy
- General Counsel
- --